Related Experiment Video
Updated: Feb 14, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns
Åsa Parke1,2, Benedikt Strunz2, Puran Chen2
1Department of Infectious Diseases, Karolinska University Hospital, 141 57 Stockholm, Sweden.
Insights
Calprotectin is a potential biomarker for severe COVID-19 and sepsis. High calprotectin levels in patients with COVID-19 indicate neutrophil-driven inflammation and disease severity.
Area of Science:
- Immunology
- Proteomics
- Infectious Diseases
Background:
- Calprotectin is a potential biomarker for severe COVID-19 and sepsis.
- The biological role of calprotectin in these conditions requires further investigation.
Purpose of the Study:
- To investigate the association between serum calprotectin and the circulating proteome in COVID-19 patients.
- To explore calprotectin's role as a biomarker in viral sepsis.
Main Methods:
- Observational study of 160 hospitalized adult COVID-19 patients.
- Serum calprotectin measured by turbidimetric assay.
- Proteomics analyzed using the Olink Explore 1536 platform.
Main Results:
- Higher median calprotectin levels in severe versus moderate COVID-19.
- Calprotectin associated with a neutrophil-centered inflammatory proteomic signature.
- Strongest correlation found between calprotectin and S100A12.
Conclusions:
- Calprotectin is associated with COVID-19 disease severity.
- High calprotectin reflects neutrophil-mediated hyperinflammation in viral sepsis.
- Findings support calprotectin as a biomarker for neutrophil-driven inflammation.
Abstract:
Calprotectin in blood has been identified as a potential biomarker for severe COVID-19 and sepsis. As a knowledge gap remains regarding the biological role of calprotectin, we aimed to investigate the association between serum calprotectin and the circulating proteome in patients with COVID-19 as a model for viral sepsis. In this observational study, serum samples were collected from 160 hospitalized adult patients with COVID-19. The samples were analyzed for calprotectin using a routine turbidimetric assay and for proteomics using the Olink Explore 1536 platform. Patients were classified as having severe or moderate COVID-19 according to oxygen supply on the day of blood sampling. The median calprotectin level was significantly higher in patients with severe compared to moderate COVID-19. In relation to proteomics, calprotectin levels were associated with a neutrophil-centered inflammatory proteomic signature, characterized by upregulation of cytokine and danger-signaling pathways. S100A12 showed the strongest correlation to calprotectin. In conclusion, calprotectin is associated with disease severity in COVID-19, and high levels reflect a neutrophil-driven inflammatory proteomic profile, particularly involving S100A12. These findings support calprotectin as a biomarker of neutrophil-mediated hyperinflammation in viral sepsis.
Related Concept Videos
Serum Studies: Renal Function Tests
Serum Laboratory Studies, Stool Test, Breath Test
Hospitals-II
Nurses that work in...
Hospitals-I
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

